Alvotech (ALVO) Enterprise Value (2020 - 2026)
Alvotech's (ALVO) quarterly Enterprise Value came in at -$63.8 million in Q1 2026, down 24.12% YoY from -$84.1 million in Q1 2025, and up 62.97% on a QoQ basis from -$172.4 million in Q4 2025.
Alvotech (ALVO) Enterprise Value (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Enterprise Value data on file, last reported at -$63.8 million in Q1 2026.
- Quarterly Enterprise Value fell 24.12% year-over-year to -$63.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$63.8 million (down 24.12% YoY) and the FY2025 annual result came in at -$172.4 million, down 235.15% from the prior year.
- Enterprise Value climbed to -$63.8 million in Q1 2026, from -$172.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$10.9 million in Q2 2024 to a low of -$172.4 million in Q4 2025.
- A 5-year average of -$79.9 million and a median of -$64.3 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value jumped 83.2% — and 2025, when it sank 1283.88%.
- Tracing ALVO's Enterprise Value over 5 years: stood at -$66.4 million in 2022, then jumped by 83.2% to -$11.2 million in 2023, then slumped by 360.95% to -$51.4 million in 2024, then sank by 235.15% to -$172.4 million in 2025, then jumped by 62.97% to -$63.8 million in 2026.
- The last three Enterprise Value figures came in at -$63.8 million (Q1 2026), -$172.4 million (Q4 2025), and -$51.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | -164.00 Mn |
| 10 | Alvotech | 1.23 Bn | 1.23 Bn | 5.09 Mn | -63.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.83 Mn |
| Dec 31, 2025 | -172.36 Mn |
| Sep 30, 2025 | -51.43 Mn |
| Jun 30, 2025 | -151.45 Mn |
| Mar 31, 2025 | -51.43 Mn |
| Dec 31, 2024 | -51.43 Mn |
| Sep 30, 2024 | -118.27 Mn |
| Jun 30, 2024 | -10.94 Mn |
| Mar 31, 2024 | -64.81 Mn |
| Dec 31, 2023 | -11.16 Mn |
| Jun 30, 2023 | -60.47 Mn |
| Mar 31, 2023 | -115.84 Mn |
| Dec 31, 2022 | -66.43 Mn |
| Jun 30, 2022 | -128.44 Mn |
| Dec 31, 2021 | -17.56 Mn |
| Dec 31, 2020 | -31.69 Mn |